Shanda Games Ltd. ADS (GAME) Financials Nov 14, 2014, 4:00
Shanda Games Ltd. ADS (GAME) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Shanda Games Ltd. ADS
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 703.75M 666.52M 819.22M 743.01M 707.45M
Cost of Goods Sold (COGS) incl. D&A 283.08M 271.83M 318.88M 271.58M 184.93M
COGS excluding D&A 254.29M 226.91M 264.16M 228.55M 133.31M
Depreciation & Amortization Expense 28.79M 44.92M 54.72M 43.04M 51.62M
Depreciation 6.56M 8.44M 11.55M 13.15M 16.09M
Amortization of Intangibles 22.23M 36.48M 43.18M 29.88M 35.53M
Gross Income 420.67M 394.69M 500.34M 471.43M 522.52M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 166.74M 197.47M 271.72M 252.71M 245.92M
Research & Development 49.74M 68.92M 107.69M 104.53M 116.28M
Other SG&A 117M 128.55M 164.03M 148.19M 129.64M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 (5.06M)
EBIT after Unusual Expense 0 0 0 0 5.06M
Non Operating Income/Expense 24.84M 31.93M 1.44M (5.76M) 51.29M
Non-Operating Interest Income 3.85M 9.13M 21.08M 36.08M 19.95M
Equity in Affiliates (Pretax) - 0 - - -
Interest Expense 0 0 3.56M 22.09M 8.17M
Gross Interest Expense 0 0 3.56M 22.09M 8.17M
Interest Capitalized 0 0 0 - 0
Pretax Income 282.61M 238.27M 276.28M 250.15M 318.79M
Income Tax 62.76M 44.44M 75.27M 66.45M 52.48M
Income Tax - Current Domestic 62.63M 45.89M 46.94M 42.43M 48.65M
Income Tax - Current Foreign 0 0 36.05M 27.42M 12.54M
Income Tax - Deferred Domestic 137,186 (1.44M) (2.32M) 1.98M (4.04M)
Income Tax - Deferred Foreign 0 0 (5.4M) (5.38M) (4.68M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates (4.4M) (795,433) (1.55M) (3.33M) (1.23M)
Other After Tax Income (Expense) 0 0 (86,546) 0 0
Consolidated Net Income 215.45M 193.04M 199.37M 180.37M 265.08M
Minority Interest Expense 2.72M 2.34M 3.27M 3.68M 6.53M
Net Income 212.73M 190.69M 196.1M 176.69M 258.56M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 212.73M 190.69M 196.1M 176.69M 258.56M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 212.73M 190.69M 196.1M 176.69M 258.56M
EPS (Basic) 0.76 0.67 0.69 0.64 0.96
Basic Shares Outstanding 278.29M 285.32M 283.57M 277.41M 268.4M
EPS (Diluted) 0.76 0.67 0.69 0.64 0.96
Diluted Shares Outstanding 279.8M 285.4M 283.59M 277.42M 268.7M
EBITDA 282.72M 242.14M 283.34M 261.75M 328.22M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...
Continue Reading
Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...
Continue Reading
Breaking Through Financial Barriers in Geothermal Energy Finally, we're seeing some real movement in the geothermal heat pump sector. The longtime hurdles that kept ground-sourced heating and cooling tech at arm's length from the everyday homeowner are starting to tumble, thanks to Enertech Global's latest initiatives. Enertech's Double Deal: A New Lease on Geothermal...
Continue Reading
The Evolving World of Agrochemicals You know, the agrochemical market isn't just about fertilizers and pesticides anymore. It's evolving into a high-stakes game of innovation, resistance management, and cutting-edge tech. This whole sector's forecast to explode to a whopping US$ 387.7 billion by 2031. That's no small potatoes. Driving Forces: Pests, Drones, and Regulatory...
Continue Reading
Insurify's Game-Changing AI Agent Gateway In the insurance world, Insurify's latest move feels like a bull charging through a ticker tape parade. This Cambridge-based pioneer unveiled its AI Agent Gateway, aiming to put consumers back in the driver's seat. By connecting digital assistant agents to its platform, Insurify's making insurance shopping a bit less like pulling...
Continue Reading
Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...
Continue Reading
Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...
Continue Reading
A Closer Look at Royce's Latest Moves Royce Small-Cap Trust (NYSE: RVT), the venerable old timer in the small-cap fund world, has been trucking along the market's bumpy byways since forever ago. With over 50 years of small- and micro-cap investment experience under its belt, you'd think it might have seen everything by now. But in the volatile world of small caps,...
Continue Reading
Top 5 Most Recently Viewed Articles
Gen Z Leads the Charge in AI-Driven Loyalty The times, they are a-changin', and loyalty programs aren't immune. Hopping on the AI bandwagon, 64% of Gen Z in the UK and 55% in the US are getting more bang for their buck, utilizing AI to optimize their participation and rake in rewards. According to Comarch's latest findings, these young savants aren't just after luxury...
Continue Reading
SendCutSend Wins Gold Stevie Award at American Business Awards SendCutSend has received a significant honor by winning a coveted Gold Stevie Award in the Manufacturing category during the American Business Awards. This prestigious award program recognizes excellence in various sectors across the country. The awards attracted over 3,600 submissions from multiple...
Continue Reading
Glow Up Golden 2026 Calendar Unveiled at Pearl River Mart -Inspired by ancient Chinese timing to support modern decision-making- In a vibrant new partnership, Julie Huang, renowned writer and Chinese metaphysics practitioner, is set to launch the Glow Up Golden 2026 Calendar at Pearl River Mart. This culturally enriching calendar draws on classical Chinese wisdom, making...
Continue Reading
Investors Encouraged to Act on Luminar Technologies Lawsuit The focus is now on Luminar Technologies, Inc. (NASDAQ: LAZR) as the opportunity arises for investors to join a significant class action lawsuit. This comes in light of recent allegations of securities fraud within the company. Investors who purchased Luminar securities within the specified time frame are urged...
Continue Reading
Recent Trends in Catalyst Pharmaceuticals' Short Interest Catalyst Pharmaceuticals (CPRX) has seen a notable increase in its short percent of float, jumping by 5.8% since the last report. The latest figures indicate that about 8.17 million shares are currently sold short, representing 8.57% of all shares available for trading. Based on trading volume, it would take...
Continue Reading